##  [FDA approves Novartis drug Promacta® for first-line SAA and grants Breakthrough Therapy designation for additional new indication](/us-en/news/media-releases/fda-approves-novartis-drug-promacta-first-line-saa-and-grants-breakthrough-therapy-designation-additional-new-indication-0 "FDA approves Novartis drug Promacta® for first-line SAA and grants Breakthrough Therapy designation for additional new indication") 

  Nov 16, 2018